Langerhans cell histiocytosis

Langerhans cell histiocytosis (LCH) is a systemic disease associated with the proliferation and accumulation (usually in granulomas) of Langerhans cells in various tissues.

Myelodysplasia

Clonal hematopoietic stem cell disorders characterized by dysplasia (ineffective production) in one or more hematopoietic cell lineages, leading to anemia and cytopenia.


合計: 4

                       


（表示件数）
PMID (PMCID)
18710527
(2527498)
 OTHER
Successful outcome of Langerhans cell histiocytosis complicated by therapy-related myelodysplasia and acute myeloid leukemia: a case report.
Al-Anazi KA, Alshehri A, Al-Zahrani HA, Al-Mohareb FI, Maghfoor I, Ajarim D.
Cases J. 2008;1(1):101.
High dose chemotherapy followed by an allograft may be a curative option not only for therapy-related myelodysplasia/acute leukemia, but also for frequently relapsing and poorly controlled Langerhans cell histiocytosis.
11025473
 MIXED_SAMPLE Infant
Concurrent Langerhans cell histiocytosis and myelodysplasia in children.
Surico G, Muggeo P, Rigillo N, Gadner H.
Med Pediatr Oncol. 2000;35(4):421-5.
Concurrent Langerhans cell histiocytosis and myelodysplasia in children.
2546462
 FEMALE Infant
Acquired immune deficiency, myelodysplasia, and acute nonlymphocytic leukemia associated with monosomy 7 and t(3;3) (q21;q26) in a child with Langerhans cell histiocytosis.
Mahoney DH Jr, McClain KL, Hanson IC, Taylor LD, Steuber CP.
Am J Pediatr Hematol Oncol. 1989;11(2):153-7.
Acquired immune deficiency, myelodysplasia, and acute nonlymphocytic leukemia associated with monosomy 7 and t(3;3) (q21;q26) in a child with Langerhans cell histiocytosis.
2546462
 FEMALE Infant
Acquired immune deficiency, myelodysplasia, and acute nonlymphocytic leukemia associated with monosomy 7 and t(3;3) (q21;q26) in a child with Langerhans cell histiocytosis.
Mahoney DH Jr, McClain KL, Hanson IC, Taylor LD, Steuber CP.
Am J Pediatr Hematol Oncol. 1989;11(2):153-7.
A case of therapy-related myelodysplasia followed by acute nonlymphocytic leukemia in a 5-year-old child successfully treated for diffuse Langerhans cell histiocytosis is described.